Target intelligence / Profile preview

Sodium- and chloride-dependent betaine transporter (BGT-1) (BGT-1)

Target
BGT-1
Molecular classification
Transporter, Solute carrier family 6
01

Overview

The Sodium- and chloride-dependent betaine transporter (BGT-1), encoded by the SLC6A12 gene, is a member of the solute carrier family 6 (SLC6) that mediates the uptake of betaine and gamma-aminobutyric acid (GABA) across cell membranes (UniProt, P48065). In the kidney, BGT-1 plays a critical role in osmoregulation by accumulating betaine as an organic osmolyte to protect cells from hypertonic stress in the renal medulla (NCBI Gene, 6539). In the central nervous system, it is primarily localized to astrocytes and contributes to the regulation of extracellular GABA levels, particularly in the leptomeninges and perivascular spaces (PubMed, 16144488). Because of its role in GABA transport, BGT-1 has emerged as a potential therapeutic target for epilepsy and other seizure disorders. Pharmacological inhibition of BGT-1 can increase synaptic GABA concentrations, potentially providing anticonvulsant effects (PubMed, 25554145). However, its dual role in osmoregulation and neurotransmission necessitates careful consideration of systemic safety, particularly regarding renal function and osmotic balance.

Other names
SLC6A12Betaine/GABA transporter 1Sodium- and chloride-dependent betaine transporterBGT1
02

Mechanism of action

Inhibition of the transport of GABA and betaine into cells, thereby increasing extracellular GABA concentrations in the brain to enhance inhibitory neurotransmission.

03

Biological functions

OsmoregulationNeurotransmissionIon transportGABA transportBetaine transport
04

Disease associations

EpilepsySeizure disordersNeurological diseaseOsmotic stress
05

Safety considerations

Potential for osmotic imbalance in the kidneyRenal toxicityCNS side effects due to GABAergic modulation
06

Interacting drugs

Tiagabine

3 more in the full profile.

07

Biomarkers

SLC6A12 expression levelsPlasma betaine concentrationCerebrospinal fluid betaine levels

Beyond the preview

Go deeper on Sodium- and chloride-dependent betaine transporter (BGT-1) (BGT-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium- and chloride-dependent betaine transporter (BGT-1) (BGT-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call